Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001181431-11-010501
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-15 17:39:37
Reporting Period:
2011-02-14
Filing Date:
2011-02-15
Accepted Time:
2011-02-15 17:39:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1392380 Gevo Inc. GEVO Industrial Organic Chemicals (2860) 870747704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1083218 Ganesh Kishore No. 36-01, Level Menara Dion
27, Jalan Sultan Ismail
50250 Kuala Lumpur N8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-14 1,540,739 $0.00 1,540,739 No 4 C Indirect By fund
Common Stock Acquisiton 2011-02-14 130,686 $15.00 1,671,425 No 4 P Indirect By fund
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By fund
No 4 P Indirect By fund
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2011-02-14 802,920 $0.00 802,920 $0.00
Common Stock Series D Preferred Stock Disposition 2011-02-14 497,160 $0.00 497,160 $0.00
Common Stock Series D-1 Preferred Stock Disposition 2011-02-14 126,515 $0.00 240,659 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Represents the aggregate number of shares of common stock deemed to be beneficially owned by the reporting person following conversion of the shares of preferred stock previously deemed to be beneficially owned by the reporting person and reflected in Table II of this Form 4.
  2. Upon completion of the Issuer's initial public offering of common stock, all shares of preferred stock deemed to be beneficially owned by the reporting person, other than shares of Series D-1 Preferred Stock, were automatically converted into shares of the Issuer's common stock on a one-for-one basis and had no expiration date.
  3. Upon completion of the Issuer's initial public offering and in accordance with the terms of the Issuer's Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on May 4, 2010, a copy of which is attached as Exhibit 3.1 to the Issuer's Registration Statement on Form S-1 (File No. 333-168792), as amended, initially filed with the Securities and Exchange Commission on August 12, 2010, the Series D-1 Preferred Stock was automatically converted into shares of the Issuer's common stock at a ratio of 1:1.90222 and had no expiration date.
  4. The securities were issued to Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.